370
Views
37
CrossRef citations to date
0
Altmetric
Tryptamine and Phenethylamine Use

“Research Chemicals”: Tryptamine and Phenethylamine Use Among High-Risk Youth

, , &
Pages 389-402 | Published online: 03 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Álvaro José Palma-Conesa, Mireia Ventura, Liliana Galindo, Francina Fonseca, Marc Grifell, Pol Quintana, Iván Fornís, Cristina Gil, Magí Farré & Marta Torrens. (2017) Something New about Something Old: A 10-Year Follow-Up on Classical and New Psychoactive Tryptamines and Results of Analysis. Journal of Psychoactive Drugs 49:4, pages 297-305.
Read now
MathiasB. Forrester. (2013) 2C Series Phenethylamine Derivative Exposures in Texas. Substance Abuse 34:1, pages 81-82.
Read now
Justin Sacks, M. Jordan Ray, Sue Williams & Michael J. Opatowsky. (2012) Fatal Toxic Leukoencephalopathy Secondary to Overdose of a New Psychoactive Designer Drug 2C-E (“Europa”). Baylor University Medical Center Proceedings 25:4, pages 374-376.
Read now

Articles from other publishers (34)

Roy Gerona. 2024. Designer Drugs. Designer Drugs 65 98 .
Sony Hartono Wijaya, Ahmad Kamal Nasution, Irmanida Batubara, Pei Gao, Ming Huang, Naoaki Ono, Shigehiko Kanaya & Md. Altaf-Ul-Amin. (2023) Deep Learning Approach for Predicting the Therapeutic Usages of Unani Formulas towards Finding Essential Compounds. Life 13:2, pages 439.
Crossref
William Feeney, Arun S. Moorthy & Edward Sisco. (2022) Spectral trends in GC-EI-MS data obtained from the SWGDRUG mass spectral library and literature: A resource for the identification of unknown compounds. Forensic Chemistry 31, pages 100459.
Crossref
Bradley Kaptur, Nicholas Peterman & Jan Lee. (2022) Nutraceuticals and dietary supplements: Disparities in usage and potential for harm. Nutrition and Health 28:3, pages 325-330.
Crossref
Sylvana Vilca-Melendez, Malin V. Uthaug & Julian L. Griffin. (2021) 1H Nuclear Magnetic Resonance: A Future Approach to the Metabolic Profiling of Psychedelics in Human Biofluids?. Frontiers in Psychiatry 12.
Crossref
Liana Fattore, Matteo Marti, Rafaela Mostallino & Maria Paola Castelli. (2020) Sex and Gender Differences in the Effects of Novel Psychoactive Substances. Brain Sciences 10:9, pages 606.
Crossref
Máté Kapitány-Fövény, Ornella Corazza, Shanna Marrinan & Zsolt Demetrovics. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions 307 325 .
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions 295 425 .
. 2020. The Cambridge Handbook of Substance and Behavioral Addictions. The Cambridge Handbook of Substance and Behavioral Addictions.
Carlo Alessandro Locatelli, Davide Lonati & Valeria Margherita Petrolini. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics 1 27 .
Carlo Alessandro Locatelli, Davide Lonati & Valeria Margherita Petrolini. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics 843 868 .
Andrey Viktorovich Antsyborov & Irina Vladimirovna Dubatova. (2019) New psychoactive substances: psychiatrist's view. Interactive science:6 (40), pages 57-67.
Crossref
Ryan Graddy, Megan E. Buresh & Darius A. Rastegar. (2018) New and Emerging Illicit Psychoactive Substances. Medical Clinics of North America 102:4, pages 697-714.
Crossref
Julian A. Michely, Simon D. Brandt, Markus R. Meyer & Hans H. Maurer. (2016) Biotransformation and detectability of the new psychoactive substances N,N-diallyltryptamine (DALT) derivatives 5-fluoro-DALT, 7-methyl-DALT, and 5,6-methylenedioxy-DALT in urine using GC-MS, LC-MSn, and LC-HR-MS/MS. Analytical and Bioanalytical Chemistry 409:6, pages 1681-1695.
Crossref
Monica J. Barratt, Simon Lenton, Alexia Maddox & Matthew Allen. (2016) ‘What if you live on top of a bakery and you like cakes?’—Drug use and harm trajectories before, during and after the emergence of Silk Road. International Journal of Drug Policy 35, pages 50-57.
Crossref
Cristina Miliano, Giovanni Serpelloni, Claudia Rimondo, Maddalena Mereu, Matteo Marti & Maria Antonietta De Luca. (2016) Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants. Frontiers in Neuroscience 10.
Crossref
Evan S. Herrmann, Patrick S. Johnson, Matthew W. Johnson & Ryan Vandrey. 2016. Neuropathology of Drug Addictions and Substance Misuse. Neuropathology of Drug Addictions and Substance Misuse 893 902 .
Dina Perrone. 2015. The Handbook of Drugs and Society. The Handbook of Drugs and Society 149 174 .
Ana Margarida Araújo, Félix Carvalho, Maria de Lourdes Bastos, Paula Guedes de Pinho & Márcia Carvalho. (2015) The hallucinogenic world of tryptamines: an updated review. Archives of Toxicology 89:8, pages 1151-1173.
Crossref
Fabrizio Schifano, Laura Orsolini, G. Duccio Papanti & John M. Corkery. (2015) Novel psychoactive substances of interest for psychiatry. World Psychiatry 14:1, pages 15-26.
Crossref
Karla D. Wagner, Richard F. Armenta, Alexis M. Roth, Jane C. Maxwell, Jazmine Cuevas-Mota & Richard S. Garfein. (2014) Use of synthetic cathinones and cannabimimetics among injection drug users in San Diego, California. Drug and Alcohol Dependence 141, pages 99-106.
Crossref
Megan E. Musselman & Jeremy P. Hampton. (2014) “ Not for Human Consumption”: A Review of Emerging Designer Drugs . Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 34:7, pages 745-757.
Crossref
Lucy Burns, Amanda Roxburgh, Raimondo Bruno & Joe Van Buskirk. (2014) Monitoring drug markets in the Internet age and the evolution of drug monitoring systems in Australia. Drug Testing and Analysis 6:7-8, pages 840-845.
Crossref
Michael E. Nelson, Sean M. Bryant & Steven E. Aks. (2014) Emerging Drugs of Abuse. Emergency Medicine Clinics of North America 32:1, pages 1-28.
Crossref
A Bakarr Kanu, Simon D. BrandtMike D. Williams, Nancy Zhang & Herbert H. Hill. (2013) Analysis of Psychoactive Cathinones and Tryptamines by Electrospray Ionization Atmospheric Pressure Ion Mobility Time-of-Flight Mass Spectrometry. Analytical Chemistry 85:18, pages 8535-8542.
Crossref
Débora González, Mireia Ventura, Fernando Caudevilla, Marta Torrens & Magi Farre. (2013) Consumption of new psychoactive substances in a Spanish sample of research chemical users. Human Psychopharmacology: Clinical and Experimental 28:4, pages 332-340.
Crossref
Be Vang Dean, Samuel J. Stellpflug, Aaron M. Burnett & Kristin M. Engebretsen. (2013) 2C or Not 2C: Phenethylamine Designer Drug Review. Journal of Medical Toxicology 9:2, pages 172-178.
Crossref
Shaun L. Greene. 2013. Novel Psychoactive Substances. Novel Psychoactive Substances 363 381 .
Fernando Caudevilla-Gálligo, Jordi Riba, Mireia Ventura, Débora González, Magí Farré, Manel J Barbanoj & José Carlos Bouso. (2012) 4-Bromo-2,5-dimethoxyphenethylamine (2C-B): presence in the recreational drug market in Spain, pattern of use and subjective effects. Journal of Psychopharmacology 26:7, pages 1026-1035.
Crossref
Markus R. Meyer & Hans H. Maurer. 2012. Metabolism of Drugs and Other Xenobiotics. Metabolism of Drugs and Other Xenobiotics 429 463 .
Simon D. Brandt, Ruchanok Tearavarich, Nicola Dempster, Nicholas V. Cozzi & Paul F. Daley. (2012) Synthesis and characterization of 5‐methoxy‐2‐methyl‐ N , N ‐dialkylated tryptamines . Drug Testing and Analysis 4:1, pages 24-32.
Crossref
Stephen E. Lankenau, Karla D. Wagner, Jennifer Jackson Bloom, Bill Sanders, Dodi Hathazi & Charles Shin. (2010) The First Injection Event: Differences among Heroin, Methamphetamine, Cocaine, and Ketamine Initiates. Journal of Drug Issues 40:2, pages 241-262.
Crossref
Bill Sanders, Stephen E. Lankenau, Jennifer Jackson Bloom & Dodi S. Hathaz. (2009) A Typology of Drug-Related Offending among Young Homeless Injection Drug Users. Journal of Drug Issues 39:4, pages 777-802.
Crossref
Dodi Hathazi, Stephen E. Lankenau, Bill Sanders & Jennifer Jackson Bloom. (2008) Pregnancy and sexual health among homeless young injection drug users. Journal of Adolescence 32:2, pages 339-355.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.